Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis

Seminars in Arthritis and Rheumatism
H Richard BarthelRoy D Altman

Abstract

Nonsteroidal anti-inflammatory drugs have dose-related adverse effects. Topical nonsteroidal anti-inflammatory drugs may offer local efficacy with low systemic drug levels. This study assessed the efficacy and safety of topical diclofenac sodium 1% gel (DSG) in mild to moderate symptomatic knee osteoarthritis. In a randomized, double-blind, vehicle-controlled trial, 492 adults aged >or=35 years with symptomatic knee osteoarthritis of >or=6 months' duration were randomized to DSG 4 g (n = 254) or vehicle (n = 238) 4 times daily for 12 weeks. Primary efficacy outcomes at week 12 were the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale, WOMAC physical function subscale, and global rating of disease. Secondary outcomes included these outcomes assessed after 1, 4, and 8 weeks, and pain on movement assessed using a 100-mm visual analog scale. All adverse events were recorded. At week 12, the DSG group had significant decreases versus the vehicle group in mean WOMAC pain (P = 0.01), mean WOMAC physical function (P = 0.001), and mean global rating of disease (P < 0.001). Efficacy outcomes significantly favored DSG versus vehicle beginning at week 1. Application site reactions occurred in 5.1% and 2....Continue Reading

References

Jun 5, 2003·Cells, Tissues, Organs·Charles J MalemudTariq M Haqqi
Dec 1, 1957·Annals of the Rheumatic Diseases·J H KELLGREN, J S LAWRENCE
Oct 25, 2003·Toxicology and Applied Pharmacology·Urs A Boelsterli
Dec 3, 2003·Annals of the Rheumatic Diseases·K M JordanUNKNOWN Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT
May 17, 2005·American Journal of Preventive Medicine·Matthew T McKennaJames S Marks
Aug 9, 2005·Seminars in Arthritis and Rheumatism·Piercarlo Sarzi-PuttiniBianca Canesi
Feb 24, 2006·The American Journal of Medicine·Gurkirpal SinghUNKNOWN SUCCESS-I Investigators
Mar 7, 2006·Current Rheumatology Reports·Sakeba N Issa, Leena Sharma
Jul 1, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Stephen P MotskoJason Worchel
Mar 21, 2007·Rheumatic Diseases Clinics of North America·Bob H SunKenneth C Kalunian
Aug 29, 2007·Clinics in Liver Disease·Guruprasad P Aithal, Christopher P Day
Mar 25, 2008·Osteoarthritis and Cartilage·T McAlindonMilton O Zucker
May 2, 2009·The American Journal of Cardiology·Michael E Farkouh, Bruce P Greenberg

❮ Previous
Next ❯

Citations

May 12, 2011·Journal of Pain Research·David R LionbergerMerrell Magelli
Jul 15, 2011·Clinical Interventions in Aging·Sanford H Roth
Aug 4, 2011·Journal of Pain Research·Sanford H Roth, Philip Fuller
May 28, 2010·Journal of Pain & Palliative Care Pharmacotherapy·Robert L Barkin
Jun 11, 2010·Pharmaceuticals·Bindu Nair, Regina Taylor-Gjevre
Feb 13, 2014·Drug Development and Industrial Pharmacy·Shabbir LoboGuang Yan
Nov 13, 2010·Current Medical Research and Opinion·Roy D Altman
May 13, 2011·Current Medical Research and Opinion·Charles E Argoff
Jan 1, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Mary Lynn McPherson, Nina M Cimino
Apr 30, 2013·Radiologic Clinics of North America·Hillary J BraunGarry E Gold
Jan 24, 2012·The American Journal of Geriatric Pharmacotherapy·Herbert S B BarafMatthew S Wieman
Mar 13, 2012·Anesthesiology Clinics·Adam Young, Asokumar Buvanendran
Feb 1, 2011·The Journal of Hand Surgery·Marco Rizzo
Sep 25, 2014·American Journal of Therapeutics·Bill H McCarberg, Byron Cryer
Jan 19, 2011·British Journal of Clinical Pharmacology·Martin BrunnerMarkus Müller
Sep 22, 2010·Pain Practice : the Official Journal of World Institute of Pain·Bradley S Galer
Aug 12, 2010·Clinics in Geriatric Medicine·William F Harvey, David J Hunter
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·Christopher M Herndon
Oct 9, 2014·Clinical Orthopaedics and Related Research·Anthony WrightPhilip Cheong
Apr 23, 2016·The Cochrane Database of Systematic Reviews·Sheena DerryR Andrew Moore
Jun 20, 2018·The Journal of Bone and Joint Surgery. American Volume·Jake Xavier CheckettsMatt Vassar
Mar 3, 2011·The Journal of Rheumatology·Roy D Altman
Jul 21, 2011·Drugs·Roy D Altman, H Richard Barthel
Sep 10, 2011·Postgraduate Medicine·Robert L BarkinAllan Gordon
Oct 28, 2011·The Physician and Sportsmedicine·Roy D Altman, Peter J Fowler
Feb 16, 2012·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Shahab BohlooliZahra Baghaei
Sep 3, 2013·Current Opinion in Anaesthesiology·Magdalena AnitescuCharles E Argoff
Oct 3, 2018·Journal of Exercise Rehabilitation·Jorge Hugo Villafañe
Nov 19, 2010·Postgraduate Medicine·H Richard Barthel, Robert A Axford-Gatley
Nov 27, 2009·Postgraduate Medicine·Rajitkanok Amy Puenpatom, Timothy W Victor
Nov 19, 2010·Postgraduate Medicine·Roy D Altman, Howard S Smith
Dec 1, 2015·Hong Kong Physiotherapy Journal : Official Publication of the Hong Kong Physiotherapy Association Limited = Wu Li Chih Liao·Adesola O OjoawoAbiodun G Badru
Jul 16, 2010·The Physician and Sportsmedicine·Herbert S BarafRoy D Altman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.